Clinical Trial Update: This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety, tolerability, and pharmacokinetics of repeat oral doses of the GSK investigational compound GSK2140944 in healthy adults;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections

Drugs mentioned

• GSK2140944

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Respiratory Tract | Phase 1 | Status: COMPLETED